Merck & Co., Inc. (MRK) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Merck & Company, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.870 -- 00:00:06.716 Thank you for standing by. Welcome to the Merck and Company, Inc., Broadway, New Jersey, 00:00:06.716 -- 00:00:09.839 USA, first quarter sales and earnings conference call. 00:00:09.839 -- 00:00:14.185 At this time, all participants are in a listen-only mode until the question and answer 00:00:14.185 -- 00:00:19.050 session of today's conference. At that time, to ask a question, press star 1 on your 00:00:19.050 -- 00:00:23.576 phone and record your name at the prompt. This call is being recorded. 00:00:23.576 -- 00:00:26.259 If you have any objections, you may disconnect at this time. 00:00:26.259 -- 00:00:28.882 I would now like to turn the call over to Mr. 00:00:28.882 -- 00:00:32.493 Peter Dannenbaum. Senior Vice President, Investor Relations. 00:00:32.493 -- 00:00:34.954 Sir, you may begin. 00:00:35.436 -- 00:00:37.539 Thank you, Julie, and good morning, everyone. 00:00:37.539 -- 00:00:41.764 Welcome to the first quarter 2026 conference call for Merck and Company Incorporated, 00:00:41.764 -- 00:00:46.770 Rodway, New Jersey, USA. Speaking on today's call will be Rob Davis, Chairman 00:00:46.770 -- 00:00:51.535 and Chief Executive Officer, Caroline Litchfield, Chief Financial Officer, and Dr. 00:00:51.535 -- 00:00:56.620 Dean Lee, President of Research Labs. Before we get started, I'd like to point out that 00:00:56.620 -- 00:01:00.405 we have items in our GAAP results, such as acquisition-related charges, restructuring 00:01:00.405 -- 00:01:04.690 costs, and certain other items that we have excluded from our non-GAAP results. 00:01:04.690 -- 00:01:07.753 There is a reconciliation in our press release. 00:01:07.753 -- 00:01:11.057 I will also remind you that some of the statements that we make today may be considered 00:01:11.0...